Breaking News

Merck Mulls Sale Of Coppertone

April 29, 2014

Will sell consumer healthcare unit for $14B.

The sun has set on Merck's sun care business—and its consumer healthcare business, too.


According to reports, Merck could agree a deal to sell its consumer healthcare operations this week for almost $14 billion, with Germany's Bayer and UK-based Reckitt Benckiser the leading companies interested in the unit. Other companies said to be in the running include, Procter & Gamble, Novartis and Sanofi.


Merck is looking to sell the operations as it only holds around 1% of the market.


A deal would be the latest in a wave of blockbuster transactions to have swept the healthcare sector recently, such as Pfizer's $100 billion-plus reported offer to acquire AstroZeneca, Valeant and Bill Ackman's $47 billion play for Allergan, Zimmer's agreement to purchase Biomet for $13.35 billion and a series of deals involving Novartis, GlaxoSmithKline and Eli Lilly.


Related End-User Markets:

Related Raw Materials:

blog comments powered by Disqus
  • What

    What's on Tap for 2016?

    Nancy Jeffries, Contributing Editor||February 8, 2016
    CEW and NPD present their beauty industry review and preview.

  • Witch

    Witch's Brew: Dickinson's celebrates milestone in 2016

    Christine Esposito, Associate Editor||February 1, 2016
    Dickinson’s celebrates 150 years of witch hazel skin care with the biggest line expansion in the company’s history.

  • From Research to Retail

    Tom Branna, Editorial Director||February 1, 2016
    What began as research on skin disorders led a dermatologist and his father to create their own skin care formulas.

  • In-Cosmetics Paris Has Sights on US

    In-Cosmetics Paris Has Sights on US

    Imogen Matthews , In-Cosmetics||December 2, 2015
    Market focus is on the USA.

  • What Do You Mean by Clean?

    What Do You Mean by Clean?

    Tom Branna, Editorial Director||November 2, 2015
    Household cleaning has undergone many changes over the years and more are on the way, as suppliers develop novel ingredients.

  • Davids and Goliaths

    Davids and Goliaths

    Christine Esposito, Associate Editor||November 2, 2015
    Big brands dominate the oral care category, but a cadre of smaller players vie for customers looking for alternatives.